400
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries : Global Cancer Statistics 2018

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions. There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. In both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths), closely followed by female breast cancer (11.6%), prostate cancer (7.1%), and colorectal cancer (6.1%) for incidence and colorectal cancer (9.2%), stomach cancer (8.2%), and liver cancer (8.2%) for mortality. Lung cancer is the most frequent cancer and the leading cause of cancer death among males, followed by prostate and colorectal cancer (for incidence) and liver and stomach cancer (for mortality). Among females, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death, followed by colorectal and lung cancer (for incidence), and vice versa (for mortality); cervical cancer ranks fourth for both incidence and mortality. The most frequently diagnosed cancer and the leading cause of cancer death, however, substantially vary across countries and within each country depending on the degree of economic development and associated social and life style factors. It is noteworthy that high-quality cancer registry data, the basis for planning and implementing evidence-based cancer control programs, are not available in most low- and middle-income countries. The Global Initiative for Cancer Registry Development is an international partnership that supports better estimation, as well as the collection and use of local data, to prioritize and evaluate national cancer control efforts. CA: A Cancer Journal for Clinicians 2018;0:1-31. © 2018 American Cancer Society.

          Related collections

          Author and article information

          Journal
          CA: A Cancer Journal for Clinicians
          CA: A Cancer Journal for Clinicians
          American Cancer Society
          00079235
          September 12 2018
          Affiliations
          [1 ]Head, Section of Cancer Surveillance, International Agency for Research on Cancer; Lyon France
          [2 ]Informatics Officer, Section of Cancer Surveillance, International Agency for Research on Cancer; Lyon France
          [3 ]Deputy Head, Section of Cancer Surveillance, International Agency for Research on Cancer; Lyon France
          [4 ]Scientific Director; Surveillance and Health Services Research, American Cancer Society; Atlanta GA
          [5 ]Scientist, Surveillance and Health Services Research, American Cancer Society; Atlanta GA
          [6 ]Scientific Vice President; Surveillance and Health Services Research, American Cancer Society; Atlanta GA
          Article
          10.3322/caac.21492
          30207593
          fa80c055-de33-499e-a379-56f81f80d4ee
          © 2018

          http://doi.wiley.com/10.1002/tdm_license_1.1

          http://onlinelibrary.wiley.com/termsAndConditions#vor

          History

          Comments

          Comment on this article